Regina E. Groves, Director at AtriCure, Inc. (ATRC), bought 500 shares at $24.86 ($12K) on 2019-09-12, disclosed to the SEC on 2019-09-16.
Open-market purchase of $12k ATRC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| ATRC | BUY | 2021-10-29 | $3K | — | Filing → |
| ATRC | SELL | 2021-09-17 | $472K | — | Filing → |
| ATRC | SELL | 2021-05-28 | $606K | — | Filing → |